Patents by Inventor John Maroney

John Maroney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240100010
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally, provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Application
    Filed: December 18, 2020
    Publication date: March 28, 2024
    Inventors: Carlos Schuler, Maithili Rairkar, Pujan Desai, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Patent number: 11932489
    Abstract: A storage, retrieval and processing system for processing objects is disclosed. The storage, retrieval and processing system includes a plurality of storage bins providing storage of a plurality of objects, where the plurality of storage bins is in communication with a retrieval conveyance system, a programmable motion device in communication with the retrieval conveyance system for receiving the storage bins from the plurality of bins, where the programmable motion device includes an end effector for grasping and moving a selected object out of a selected storage bin, and a movable carriage for receiving the selected object from the end effector of the programmable motion device, and for carrying the selected object to one of a plurality of destination bins.
    Type: Grant
    Filed: May 9, 2022
    Date of Patent: March 19, 2024
    Assignee: Berkshire Grey Operating Company, Inc.
    Inventors: Thomas Wagner, Kevin Ahearn, John Richard Amend, Jr., Benjamin Cohen, Michael Dawson-Haggerty, William Hartman Fort, Christopher Geyer, Victoria Hinchey, Jennifer Eileen King, Thomas Koletschka, Michael Cap Koval, Kyle Maroney, Matthew T. Mason, William Chu-Hyon McMahan, Gene Temple Price, Joseph Romano, Daniel Smith, Siddhartha Srinivasa, Prasanna Velagapudi, Thomas Allen
  • Publication number: 20240070094
    Abstract: A method for controlling aggregation for HRAM comprises a processing device, using a buffer manager, to receive instructions that include smaller-sized block write instructions from a host system. The processing device, using an aggregation engine, aggregates the smaller-sized block write instructions from the buffer manager into a plurality of larger-sized write instructions. The processing device issues a burst write instruction comprising the larger-sized write instructions to the memory component via the interface. The memory component can be HRAM and the interface can be a modified DDR-L5 interface for HRAM. Other embodiments are described herein.
    Type: Application
    Filed: August 17, 2023
    Publication date: February 29, 2024
    Inventor: John Maroney
  • Publication number: 20240016731
    Abstract: Provided herein are drug implants comprising apalutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and apalutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.
    Type: Application
    Filed: September 27, 2021
    Publication date: January 18, 2024
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Keith Hall, Pamela Munster, John Maroney
  • Publication number: 20230255883
    Abstract: Provided herein are drug implants comprising enzalutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and enzalutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.
    Type: Application
    Filed: April 25, 2023
    Publication date: August 17, 2023
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Keith Hall, Pamela Munster, John Maroney, Scott Thomas
  • Patent number: 11666528
    Abstract: Provided herein are drug implants comprising enzalutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and enzalutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: June 6, 2023
    Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Keith Hall, Pamela Munster, John Maroney, Scott Thomas
  • Publication number: 20230137168
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally, provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Application
    Filed: December 18, 2020
    Publication date: May 4, 2023
    Inventors: Carlos Schuler, Maithill Rairkar, Pujan Desai, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Publication number: 20230080240
    Abstract: Provided herein are drug implants comprising enzalutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and enzalutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.
    Type: Application
    Filed: April 25, 2022
    Publication date: March 16, 2023
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Keith Hall, Pamela Munster, John Maroney, Scott Thomas
  • Patent number: 11344526
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: May 31, 2022
    Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Patent number: 11338119
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: May 24, 2022
    Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Patent number: 11173291
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: November 16, 2021
    Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Publication number: 20210290920
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Application
    Filed: March 20, 2020
    Publication date: September 23, 2021
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Publication number: 20210290584
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Application
    Filed: March 20, 2020
    Publication date: September 23, 2021
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Publication number: 20210290919
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Application
    Filed: March 20, 2020
    Publication date: September 23, 2021
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Patent number: 10956344
    Abstract: An indication of a capacity of a CMB elasticity buffer and an indication of a throughput of one or more memory components associated with the CMB elasticity buffer can be received. An amount of time for data at the CMB elasticity buffer to be transmitted to one or more memory components can be determined based on the capacity of the CMB elasticity buffer and the throughput of the one or more memory components. Write data can be transmitted from a host system to the CMB elasticity buffer based on the determined amount of time for data at the CMB elasticity buffer to be transmitted to the one or more memory components.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: March 23, 2021
    Assignee: Micron Technology, Inc.
    Inventors: John Maroney, Paul Suhler, Lyle Adams, David Springberg
  • Publication number: 20200257638
    Abstract: An indication of a capacity of a CMB elasticity buffer and an indication of a throughput of one or more memory components associated with the CMB elasticity buffer can be received. An amount of time for data at the CMB elasticity buffer to be transmitted to one or more memory components can be determined based on the capacity of the CMB elasticity buffer and the throughput of the one or more memory components. Write data can be transmitted from a host system to the CMB elasticity buffer based on the determined amount of time for data at the CMB elasticity buffer to be transmitted to the one or more memory components.
    Type: Application
    Filed: April 30, 2020
    Publication date: August 13, 2020
    Inventors: John Maroney, Paul Suhler, Lyle Adams, David Springberg
  • Patent number: 10657078
    Abstract: An indication of a capacity of a CMB elasticity buffer and an indication of a throughput of one or more memory components associated with the CMB elasticity buffer can be received. An amount of time for data at the CMB elasticity buffer to be transmitted to one or more memory components can be determined based on the capacity of the CMB elasticity buffer and the throughput of the one or more memory components. Write data can be transmitted from a host system to the CMB elasticity buffer based on the determined amount of time for data at the CMB elasticity buffer to be transmitted to the one or more memory components.
    Type: Grant
    Filed: December 31, 2018
    Date of Patent: May 19, 2020
    Assignee: Micron Technology, Inc.
    Inventors: John Maroney, Paul Suhler, Lyle Adams, David Springberg
  • Publication number: 20200133897
    Abstract: An indication of a capacity of a CMB elasticity buffer and an indication of a throughput of one or more memory components associated with the CMB elasticity buffer can be received. An amount of time for data at the CMB elasticity buffer to be transmitted to one or more memory components can be determined based on the capacity of the CMB elasticity buffer and the throughput of the one or more memory components. Write data can be transmitted from a host system to the CMB elasticity buffer based on the determined amount of time for data at the CMB elasticity buffer to be transmitted to the one or more memory components.
    Type: Application
    Filed: December 31, 2018
    Publication date: April 30, 2020
    Inventors: John Maroney, Paul Suhler, Lyle Adams, David Springberg
  • Patent number: 9535472
    Abstract: The present invention relates to methods and systems for providing reliable power to a storage device, such as a network attached storage. In one embodiment, the storage device employs a redundant power backplane design using a DC-to-DC converter per drive in the backplane. Each drive is thus provided its own independent power interface to the power backplane. One embodiment may employ DC-to-DC converters having integrated N-channel MOSFETs to provide overcurrent and thermal protection. In addition, an embodiment may employ a staggered startup procedure to manage peak power draw.
    Type: Grant
    Filed: March 31, 2012
    Date of Patent: January 3, 2017
    Assignee: Western Digital Technologies, Inc.
    Inventor: John Maroney
  • Patent number: 9180016
    Abstract: A kit for use in shoulder arthroplasty includes a tamp configured to form a generally oval cavity in grafting material in a glenoid vault, the tamp including a body and a forming portion shaped complementary to the oval cavity, and a glenoid component including a body having a stem portion with an oval cross section for inserting at least partially into the generally oval cavity, the stem portion configured to substantially fill the glenoid vault.
    Type: Grant
    Filed: February 3, 2014
    Date of Patent: November 10, 2015
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Brian John Maroney, Gerald Ross Williams